- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
In vivo CAR T cell therapy against angioimmunoblastic T cell lymphoma ; volume:43 ; number:1 ; day:14 ; month:9 ; year:2024 ; pages:1-18 ; date:12.2024
Journal of experimental & clinical cancer research ; 43, Heft 1 (14.9.2024), 1-18, 12.2024
- Urheber
-
Krug, Adrien
Saidane, Aymen
Martinello, Chiara
Fusil, Floriane
Michels, Alexander
Buchholz, Christian J.
Ricci, Jean-Ehrland
Verhoeyen, Els
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13046-024-03179-5
- URN
-
urn:nbn:de:101:1-2411282059408.428007538856
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:25 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Krug, Adrien
- Saidane, Aymen
- Martinello, Chiara
- Fusil, Floriane
- Michels, Alexander
- Buchholz, Christian J.
- Ricci, Jean-Ehrland
- Verhoeyen, Els
- SpringerLink (Online service)
Ähnliche Objekte (12)
Nanobody-armed T cells endow CAR-T cells with cytotoxicity against lymphoma cells
CAR T-cell therapy in diffuse large B-cell lymphoma
CAR-T cells targeting CD38 and LMP1 exhibit robust antitumour activity against NK/T cell lymphoma
CAR T-Cell therapy for the management of mantle cell lymphoma
Switchable CAR T cell strategy against osteosarcoma
In vivo generated human CAR T cells eradicate tumor cells
Transgenic expression of IL-7 regulates CAR-T cell metabolism and enhances in vivo persistence against tumor cells
Treatment of Aggressive T Cell Lymphoblastic Lymphoma/leukemia Using Anti-CD5 CAR T Cells
A good response of refractory mantel cell lymphoma to haploidentical CAR T cell therapy after failure of autologous CAR T cell therapy
Gallic acid enhances anti-lymphoma function of anti-CD19 CAR-T cells in vitro and in vivo
Recent advances in CAR T-cell therapy for lymphoma in China
CAR T-cell therapy in diffuse large B-cell lymphoma : a practical resource for nurses
Nanobody-armed T cells endow CAR-T cells with cytotoxicity against lymphoma cells
CAR T-cell therapy in diffuse large B-cell lymphoma
CAR-T cells targeting CD38 and LMP1 exhibit robust antitumour activity against NK/T cell lymphoma
CAR T-Cell therapy for the management of mantle cell lymphoma
Switchable CAR T cell strategy against osteosarcoma
In vivo generated human CAR T cells eradicate tumor cells
Transgenic expression of IL-7 regulates CAR-T cell metabolism and enhances in vivo persistence against tumor cells
Treatment of Aggressive T Cell Lymphoblastic Lymphoma/leukemia Using Anti-CD5 CAR T Cells
A good response of refractory mantel cell lymphoma to haploidentical CAR T cell therapy after failure of autologous CAR T cell therapy
Gallic acid enhances anti-lymphoma function of anti-CD19 CAR-T cells in vitro and in vivo
Recent advances in CAR T-cell therapy for lymphoma in China
CAR T-cell therapy in diffuse large B-cell lymphoma : a practical resource for nurses
Nanobody-armed T cells endow CAR-T cells with cytotoxicity against lymphoma cells
CAR T-cell therapy in diffuse large B-cell lymphoma
CAR-T cells targeting CD38 and LMP1 exhibit robust antitumour activity against NK/T cell lymphoma
CAR T-Cell therapy for the management of mantle cell lymphoma
Switchable CAR T cell strategy against osteosarcoma
In vivo generated human CAR T cells eradicate tumor cells
Transgenic expression of IL-7 regulates CAR-T cell metabolism and enhances in vivo persistence against tumor cells
Treatment of Aggressive T Cell Lymphoblastic Lymphoma/leukemia Using Anti-CD5 CAR T Cells
A good response of refractory mantel cell lymphoma to haploidentical CAR T cell therapy after failure of autologous CAR T cell therapy
Gallic acid enhances anti-lymphoma function of anti-CD19 CAR-T cells in vitro and in vivo
Recent advances in CAR T-cell therapy for lymphoma in China